Barclays »

Aclaris Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $184k 176k 1.05
2023-09-30 $1.6M 234k 6.85
2023-06-30 $885k 85k 10.37
2023-03-31 $1.5M 189k 8.09
2022-12-31 $674k 43k 15.73
2022-09-30 $263k 17k 15.72
2022-06-30 $307k 22k 13.97
2022-03-31 $1.0M 60k 17.24
2021-12-31 $1.5M 101k 14.53
2021-09-30 $903k 50k 18.00
2021-06-30 $206k 12k 17.48
2021-03-31 $0 18 0.00
2020-12-31 $0 18 0.00
2020-09-30 $0 18 0.00
2020-06-30 $13k 8.3k 1.57
2020-03-31 $11k 11k 1.06
2019-12-31 $158k 84k 1.88
2019-09-30 $18k 17k 1.04
2019-06-30 $51k 23k 2.19
2019-03-31 $63k 11k 5.99
2018-09-30 $178k 12k 14.50
2018-06-30 $39k 2.0k 19.91
2018-03-31 $111k 6.4k 17.46
2017-12-31 $112k 4.5k 24.71
2017-09-30 $192k 7.5k 25.75
2017-06-30 $0 553 0.00
2017-03-31 $169k 5.6k 30.09
2016-12-31 $145k 5.4k 27.10
2016-09-30 $4.0k 153 26.14
2015-12-31 $26k 1.0k 26.00